Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avis Budget

61.95
+6.4611.64%
Post-market: 62.780.8320+1.34%19:43 EDT
Volume:2.11M
Turnover:126.99M
Market Cap:2.18B
PE:-1.21
High:63.18
Open:57.52
Low:55.69
Close:55.49
Loading ...

Celyad Oncology announces the publication of the preclinical and clinical data of CYAD-211 providing proof-of-concept of its miRNA-based shRNA platform

Business Wire
·
18 Feb

Analysts’ Opinions Are Mixed on These Industrial Goods Stocks: Avis Budget (CAR), A. O. Smith Corporation (AOS) and Ingersoll Rand (IR)

TIPRANKS
·
18 Feb

Avis Budget Group’s Financial Health at Risk from Potential Impairment Charges

TIPRANKS
·
16 Feb

Avis Budget Group Earnings Call: Mixed Sentiment and Future Plans

TIPRANKS
·
14 Feb

Imugene’s Azer-cel Shows Promising Results in CAR-T Phase 1b Trial

TIPRANKS
·
14 Feb

Top Research Reports for JPMorgan, Costco & SAP

Zacks
·
14 Feb

Allogene Therapeutics Announces Publication of Durable Response Data from Phase 1 ALPHA/ALPHA2 Trials of the Allogeneic CAR T Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma in the Journal of Clinical Oncology

GlobeNewswire
·
14 Feb

Avis Budget Stock Price Decreases 7% Since Reporting Loss in Q4

Zacks
·
14 Feb

Deutsche Bank Adjusts Avis Budget Group Price Target to $138 From $136, Maintains Buy Rating

MT Newswires Live
·
13 Feb

Avis Budget Group Inc : JP Morgan Cuts Target Price to $135 From $150

THOMSON REUTERS
·
13 Feb

Avis Budget Group Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
13 Feb

CAR Group (WN6) was downgraded to a Hold Rating at Macquarie

TIPRANKS
·
13 Feb

Carclo plc Appoints Ian Tichias as New CFO

TIPRANKS
·
13 Feb

Q4 2024 Avis Budget Group Inc Earnings Call

Thomson Reuters StreetEvents
·
13 Feb

Avis Budget’s higher impairment pushed out ‘clearing event’, says Goldman Sachs

TIPRANKS
·
13 Feb

BUZZ-Avis skids after swinging to Q4 loss, CEO change

Reuters
·
12 Feb